2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Journal of Thoracic Oncology J THORAC ONCOL （此期刊被最新的JCR期刊SCIE收录） LetPub评分 9.2
50人评分
我要评分
声誉 9.9 影响力 8.6 速度 9.4 | |||||||||||||||||||||
| 期刊ISSN | 1556-0864 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1556-1380 | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：22.69 | |||||||||||||||||||||
| 2025-2026自引率 | 4.3%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 22.304数据由网友[pixelmaple466]收集提供 | |||||||||||||||||||||
| h-index | 113 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | http://www.jto.org/ | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/JTO | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors Committee Author: Ardeshir-Larinani, Fatemeh; Ashrafian, Leanne; Chiappetta, Marco; Mansilla, Daniel; Mariani, Alessandro Wasum; Menis, Jessica; Rimner, Andreas; Sharma, Aparna; Szolkowska, Malgorzata; Upadhya, Swasthik; Velotta, Jeffrey B.; Vlahos, Ioannis; Xu, Chunwei; Mansfield, Aaron S.; Baas, Paul; Roden, Anja C Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 5, pp. -. DOI: 10.1016/j.jtho.2026.103611 Bispecific T-cell Engager (CD3 × EGFR)-Based Triplet Therapy Unlocks CD40/CD40L Crosstalk to Revert Immunosuppression in Third-Generation EGFR-Tyrosine Kinase Inhibitor-Refractory NSCLC Author: Guo, Haoyue; Wang, Yuanyuan; Diao, Meng; Han, Ruoshuang; He, Taiping; Wu, Yuhan; Wang, Qianyi; Cheng, Lei; Zhao, Chao; Li, Xuefei; Xiong, Anwen; Li, Wei; Zhou, Fei; Zhou, Caicun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 5, pp. -. DOI: 10.1016/j.jtho.2026.103607 Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact (vol 21, pg 41, 2026) Author: Carbone, Michele; Amos, Christopher; Attanoos, Richard L.; Boeri, Mattia; Bueno, Raphael; Bunn, Paul A.; Chirieac, Lucian R.; Cooper, Benjamin; Fennell, Dean; Galateau-Salle, Francoise; Giannakou, Lydia; Goparaju, Chandra, V; Hassan, Raffit; Hofman, Paul; Kris, Mark G.; Mao, Weimin; Minaai, Michael; Mitsudomi, Tsetsuya; Molina, Thierry J.; Montuenga, Luis M.; Nabeshima, Kazuki; Passaro, Antonio; Peters, Solange; Rajan, Arun; Richardson, David B.; Robbins, Hilary; Rolfo, Christian; Rudin, Charles M.; Samet, Jonathan M.; Scherpereel, Arnaud; Schrump, David S.; Sozzi, Gabriella; Taioli, Emanuela; Visona, Silvia D.; Yang, Haining; Yoshikawa, Yoshie; Zhao, An; Pass, Harvey I Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 4, pp. -. DOI: 10.1016/j.jtho.2026.103576 GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma Author: Zhang, Xiaoshen; Wen, Yaokai; Wu, Fengying; Jiang, Yu; Lin, Yuechun; Wang, Lei; Zhou, Fei; Shen, Yue; Min, Zhen; Li, Wei; Liang, Wenhua; He, Jianxing; Zhou, Caicun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.001 | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Journal of Thoracic Oncology的语言要求，还能让Journal of Thoracic Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Journal of Thoracic Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | No | |||||||||||||||||||||
| 通讯方式 | LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621 | |||||||||||||||||||||
| 出版商 | International Association for the Study of Lung Cancer | |||||||||||||||||||||
| 涉及的研究方向 | 医学-呼吸系统 | |||||||||||||||||||||
| 出版国家或地区 | UNITED STATES | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Monthly | |||||||||||||||||||||
| 出版年份 | 2006 | |||||||||||||||||||||
| 年文章数 | 108点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 27.60% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 93.52% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 一般,3-6周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 较易 | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Journal of Thoracic Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 。 提交文稿 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Challenges and Controversies in the Diagnosis and Management of Thymic Epithelial Tumors from the Thymic Tumor Subcommittee of the International Association for the Study of Lung Cancer Rare Tumors Committee Author: Ardeshir-Larinani, Fatemeh; Ashrafian, Leanne; Chiappetta, Marco; Mansilla, Daniel; Mariani, Alessandro Wasum; Menis, Jessica; Rimner, Andreas; Sharma, Aparna; Szolkowska, Malgorzata; Upadhya, Swasthik; Velotta, Jeffrey B.; Vlahos, Ioannis; Xu, Chunwei; Mansfield, Aaron S.; Baas, Paul; Roden, Anja C Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 5, pp. -. DOI: 10.1016/j.jtho.2026.103611 PubMed DOI |
| 2. | Bispecific T-cell Engager (CD3 × EGFR)-Based Triplet Therapy Unlocks CD40/CD40L Crosstalk to Revert Immunosuppression in Third-Generation EGFR-Tyrosine Kinase Inhibitor-Refractory NSCLC Author: Guo, Haoyue; Wang, Yuanyuan; Diao, Meng; Han, Ruoshuang; He, Taiping; Wu, Yuhan; Wang, Qianyi; Cheng, Lei; Zhao, Chao; Li, Xuefei; Xiong, Anwen; Li, Wei; Zhou, Fei; Zhou, Caicun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 5, pp. -. DOI: 10.1016/j.jtho.2026.103607 PubMed DOI |
| 3. | Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact (vol 21, pg 41, 2026) Author: Carbone, Michele; Amos, Christopher; Attanoos, Richard L.; Boeri, Mattia; Bueno, Raphael; Bunn, Paul A.; Chirieac, Lucian R.; Cooper, Benjamin; Fennell, Dean; Galateau-Salle, Francoise; Giannakou, Lydia; Goparaju, Chandra, V; Hassan, Raffit; Hofman, Paul; Kris, Mark G.; Mao, Weimin; Minaai, Michael; Mitsudomi, Tsetsuya; Molina, Thierry J.; Montuenga, Luis M.; Nabeshima, Kazuki; Passaro, Antonio; Peters, Solange; Rajan, Arun; Richardson, David B.; Robbins, Hilary; Rolfo, Christian; Rudin, Charles M.; Samet, Jonathan M.; Scherpereel, Arnaud; Schrump, David S.; Sozzi, Gabriella; Taioli, Emanuela; Visona, Silvia D.; Yang, Haining; Yoshikawa, Yoshie; Zhao, An; Pass, Harvey I Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 4, pp. -. DOI: 10.1016/j.jtho.2026.103576 PubMed DOI |
| 4. | GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma Author: Zhang, Xiaoshen; Wen, Yaokai; Wu, Fengying; Jiang, Yu; Lin, Yuechun; Wang, Lei; Zhou, Fei; Shen, Yue; Min, Zhen; Li, Wei; Liang, Wenhua; He, Jianxing; Zhou, Caicun Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.001 PubMed DOI |
| 5. | Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alterations Author: Peng, Li-Shan; Cui, Qian; Zhang, Chao; Lin, Jun-Tao; Wu, You; Kang, Jin; Xu, Zi-Yi; Wang, Xiang-Yang; Cao, Ying-Jiao; Zhang, Qing-Ling; Wu, Yi-Long; Hu, Zheng; Zhong, Wen-Zhao Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.10.013 PubMed DOI |
| 6. | Andamertinib in Advanced NSCLC With EGFR Exon 20 Insertions After Platinum-Based Chemotherapy or Immunotherapy: Results From the Phase 2 KANNON Study Author: Yang, Jin-Ji; Mu, Yu; Wang, Zhe-Hai; Duan, Jian-Chun; Zhang, Yan; Wu, Lin; Zhong, Hua; Zhao, Jun; Yao, Yu; Wang, Ping; Li, Xiao-Ling; Yang, Run-Xiang; Min, Xu-Hong; Lv, Dong-Qing; Xu, Hai-Peng; Fu, Zhen-Ming; Shen, Bo; Sun, Long-Hua; Wang, Chang-Li; Zhou, Jian-Ya; Xu, Rui-Lian; Ma, Hui-Wen; Zhao, Yan-Qiu; Shi, He-Peng; Zhang, Pei-Long; Xue, Wei-Zhe; Han, Di; Zheng, Yi; Wu, Yi-Long Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.008 PubMed DOI |
| 7. | Radiotherapy for Unresectable Locally Advanced NSCLC: A Practical Multidisciplinary Approach to Challenging Scenarios From the International Association for the Study of Lung Cancer Advanced Radiation Technology Subcommittee Author: Zhu, Hongcheng; Al Saifi, Said; Bahig, Houda; Cooper, Alissa; Abrao, Fernando Conrado; Corrales, Luis; Faivre-Finn, Corinne; Filippi, Andrea Riccardo; Fitzgerald, Bailey; Khosla, Divya; Lam, Vincent K.; Le, Xiuning; Menezes, Vanessa; Newsom-Davis, Tom; Qin, Angel; Putora, Paul Martin; Munoz-Schuffenegger, Pablo; Siva, Shankar; Yu, Nathan Y.; Louie, Alexander, V Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 3, pp. -. DOI: 10.1016/j.jtho.2025.11.006 PubMed DOI |
| 8. | Response to Letter to the Editor: Refining Immunochemoradiotherapy for Patients With NSCLC and Brain Metastases: Insights on Biomarkers, Neuroprotection, and Global Applicability Author: Li, Yang-Si; Yang, Jin-Ji; Wu, Yi-Long Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 335-336. DOI: 10.1016/j.jtho.2025.08.023 PubMed DOI |
| 9. | A Game-Changing 20 Years: Progress and Future Directions in Lung Cancer Screening Author: Lam, Stephen; Baldwin, David R.; Devaraj, Anand; Field, John; Henschke, Claudia I.; Heuvelmans, Marjolein A.; Huber, Rudolf M.; Jones, Catherine; Borondy-Kitts, Andrea; Li, Molly Siu Ching; Myers, Renelle; Osarogiagbon, Raymond U.; Robbins, Hilary A.; Tammemagi, Martin C.; Taylor, Kathryn L.; Triphuridet, Natthaya; Williams, Randi M.; Yankelevitz, David Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 235-252. DOI: 10.1016/j.jtho.2025.11.017 PubMed DOI |
| 10. | A Grading System for Resected Invasive Squamous Cell Carcinoma of the Lung: A Multi-Institutional Study by the IASLC Pathology Committee Author: Mino-Kenudson, Mari; Berezowska, Sabina; Minami, Yuko; Chen, Shuyan; Ray, Meredith A.; Rerkpichaisuth, Vilasinee; Hashisako, Mikiko; Losmanova, Tereza; Hayashi, Takuo; Shim, Hyo-Sup; Righi, Luisella; Gagne, Andreanne; Kim, Tae-Jung; Bubendorf, Lukas; Lopez-Rios, Fernando; Matsubara, Daiske; Von Der Thusen, Jan; Lantuejoul, Sylvie; Roden, Anja C.; Nicholson, Andrew; Jain, Deepali; Han, Yuchen; Wynes, Murry W.; Dacic, Sanja; Smeltzer, Mathew P.; Cooper, Wendy A.; Papotti, Mauro G Journal: JOURNAL OF THORACIC ONCOLOGY. 2026; Vol. 21, Issue 2, pp. 294-309. DOI: 10.1016/j.jtho.2025.09.1761 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共46条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
